Dinah Sah Ph.D., Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 31,246 shares at $30.00 ($625K) on 2018-02-27, disclosed to the SEC on 2018-03-01.
Open-market sale of $625k VYGR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.27 | 2,184 | $16K | 2.5% |
| 2 | $8.33 | 4,376 | $36K | 5.8% |
| 3 | $11.09 | 5,000 | $55K | 8.9% |
| 4 | $11.83 | 4,063 | $48K | 7.7% |
| 5 | $30.00 | 15,623 | $469K | 75.0% |
| Total | $19.99 avg | 31,246 |
| $625K |
| 100% |